Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.

Biotechnology

Education

Code Bio

Code Bio's headquarters in Hatfield, PA, United States

Brian P. McVeigh

Samantha Brown

Matthew Roberts

Sai Abhishek

Paula Carpenter

Alex T.

Alexander Tracy

Keith G. Dewedoff

Kathy R.

James Bauersmith

Russ Fein

Dima Kuzmin

Jason Baranski

Diana Bernstein

Ed Mathers

Kathy Rouan

The Research and Development team at Code Biotherapeutics is dedicated to advancing innovative non-viral gene therapies by conducting cutting-edge scientific research and developing robust platforms for targeted treatments. This interdisciplinary team of experts—including research scientists, cellular biologists, and molecular biochemists—collaborates on discovery, assay development, and preclinical processes to ensure the efficacy and safety of therapeutic solutions for genetic diseases. Additionally, they oversee the transition from laboratory developments to scalable production, maintaining high standards in analytical methods and environmental health and safety.

Research and Development

The Business Operations team at Code Biotherapeutics is responsible for aligning strategic initiatives with operational execution to drive the company's mission of developing innovative gene therapies. This team oversees business development, legal compliance, project management, and financial strategies, ensuring a cohesive approach to advancing therapeutic solutions for serious genetic diseases. By fostering collaboration among senior leadership and managing critical projects, they enable efficient resource allocation and overall organizational effectiveness.

Business Operations

This department oversees strategic direction and decision-making for the organization.

Leadership

The Leadership Team at Code Bio guides the strategic direction and overall vision of the company, focusing on advancing next-generation non-viral gene therapies. Comprising top executives, including the CEO and Chief Platform Technologies Officers, they collaborate to drive innovation, foster partnerships, and ensure operational excellence in the development of targeted treatments for serious genetic diseases.

Leadership Team

This department provides strategic direction and oversight for the organization through high-level governance and decision-making.

Executive Leadership

This department oversees corporate governance and provides insights on board activities.

Code Bio

Org chart

Board & advisors

Teams

Research and Development

Business Operations

Leadership

Leadership Team

Executive Leadership

Governance Affairs

Offices

Code Bio

Org chart

Board & advisors

Teams

Research and Development

Business Operations

Leadership

Leadership Team

Executive Leadership

Governance Affairs

Offices

Related companies